Imatinib mesylate and nilotinib affect MHC-class I presentation by modulating the proteasomal processing of antigenic peptides

DSpace Repository

Imatinib mesylate and nilotinib affect MHC-class I presentation by modulating the proteasomal processing of antigenic peptides

Author: Held, Stefanie Andrea Erika; Duchardt, Katharina Maria; Tenzer, Stefan; Rueckrich, Thomas; von Schwarzenberg, Karin; Bringmann, Anita; Kurts, Christian; Schild, Hansjoerg; Driessen, Christoph; Brossart, Peter; Heine, Annkristin
Tübinger Autor(en):
Duchardt, Katharina Maria
Rückrich, Thomas
Published in: Cancer Immunology Immunotherapy (2013), Bd. 62, H. 4, S. 715-726
Verlagsangabe: Springer
Language: English
Full text: http://dx.doi.org/10.1007/s00262-012-1373-7
ISSN: 0340-7004
DDC Classifikation: 610 - Medicine and health
570 - Life sciences; biology
Dokumentart: Artikel
Show full item record

This item appears in the following Collection(s)